More than a decade has passed since the first human genome was mapped. Since then, costs have plunged and major efficiencies have been achieved. Cathie Wood, founder and CEO of Ark Invest, tells us about investment opportunities in CRISPR and CAR-T technology, the major drivers of the genomics revolution. Filmed on February 20th, 2018.
What kind of future are we building with the tools we have today? In this journey of discovery, Justine Underhill seeks to answer that question, interviewing original thinkers on what the future might bring and the unintended consequences of the tech we use.
What kind of future are we building with the tools we have today? In this journey of discovery, Justine Underhill seeks to answer that question, interviewing original thinkers on what the future might bring and the unintended consequences of the tech we use.
COMMENTS
Sort ByAccess Essential Content
This content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?
See Our PlansAlready have an account? Log In